Introduction: anti-TNF strategies in the treatment of Crohn's disease

Aliment Pharmacol Ther. 1999 Sep:13 Suppl 4:1. doi: 10.1046/j.1365-2036.1999.00030.x.

Authors

P J Rutgeerts¹, S R Targan

Affiliation

¹ University Hospital Gasthuisberg, Department of Gastroenterology, Leuven, Belgium.

PMID: 10597332
DOI: 10.1046/j.1365-2036.1999.00030.x

No abstract available

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Crohn Disease / drug therapy*
Gastrointestinal Agents / therapeutic use*
Humans
Infliximab
Quality of Life

Substances

Antibodies, Monoclonal
Gastrointestinal Agents
Infliximab